Harvard Bioscience, Inc. (HBIO)
NASDAQ: HBIO · Real-Time Price · USD
6.63
+0.28 (4.41%)
Jul 7, 2026, 4:00 PM EDT - Market closed
Harvard Bioscience Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 85.53 | 86.55 | 94.14 | 112.25 | 113.34 | 118.9 | |
Revenue Growth (YoY) | -6.42% | -8.06% | -16.14% | -0.96% | -4.68% | 16.46% |
Cost of Revenue | 35.56 | 36.64 | 39.37 | 46.18 | 52.52 | 51.25 |
Gross Profit | 49.97 | 49.91 | 54.77 | 66.07 | 60.82 | 67.65 |
Selling, General & Admin | 36.84 | 36.96 | 43.71 | 46.82 | 49.53 | 48.95 |
Depreciation & Amortization Expenses | 3.69 | 4.03 | 5.26 | 5.53 | 6.12 | 5.84 |
Research & Development | 8.83 | 8.83 | 10.41 | 11.76 | 12.33 | 10.8 |
Other Operating Expenses | 0.7 | 48.68 | 1.61 | 0.07 | -0.23 | - |
Total Operating Expenses | 50.06 | 98.49 | 60.98 | 64.18 | 67.75 | 65.59 |
Operating Income | -0.09 | -48.58 | -6.21 | 1.89 | -6.93 | 2.07 |
Interest Expense | -5.84 | -4.92 | -3.54 | -3.59 | -2.55 | -1.54 |
Other Non-Operating Income (Expense) | -10.82 | -12.7 | -7.37 | -5.31 | -1.94 | -2.87 |
Total Non-Operating Income (Expense) | -16.67 | -17.61 | -10.91 | -8.9 | -4.49 | -4.41 |
Pretax Income | -16.75 | -66.19 | -17.12 | -7.01 | -11.43 | -2.35 |
Provision for Income Taxes | -0.12 | -0.69 | 0.74 | 0.86 | 0.34 | 0.15 |
Net Income | -16.64 | -65.51 | -17.86 | -7.87 | -11.76 | -2.49 |
Net Income to Common | -9.78 | -56.7 | -12.41 | -3.42 | -9.52 | -0.29 |
Shares Outstanding (Basic) | 4 | 4 | 4 | 4 | 4 | 4 |
Shares Outstanding (Diluted) | 4 | 4 | 4 | 4 | 4 | 4 |
Shares Change (YoY) | 1.44% | 1.96% | 2.64% | 2.43% | 2.65% | 4.41% |
EPS (Basic) | -2.17 | -12.80 | -2.80 | -0.80 | -2.30 | -0.10 |
EPS (Diluted) | -2.17 | -12.80 | -2.80 | -0.80 | -2.30 | -0.10 |
Free Cash Flow | 1.91 | 5.47 | -1.2 | 12.24 | -0.44 | 0.07 |
Free Cash Flow Growth | -65.09% | - | - | - | - | -99.18% |
Free Cash Flow Per Share | 0.43 | 1.23 | -0.28 | 2.89 | -0.11 | 0.02 |
Gross Margin | 58.42% | 57.67% | 58.18% | 58.86% | 53.66% | 56.90% |
Operating Margin | -0.10% | -56.13% | -6.60% | 1.69% | -6.12% | 1.74% |
Profit Margin | -19.45% | -75.69% | -18.97% | -7.01% | -10.38% | -2.10% |
FCF Margin | 2.23% | 6.32% | -1.28% | 10.90% | -0.39% | 0.06% |
EBITDA | 5.55 | -42.64 | 0.95 | 8.89 | 0.64 | 9.69 |
EBITDA Margin | 6.49% | -49.26% | 1.00% | 7.92% | 0.57% | 8.15% |
EBIT | -0.09 | -48.58 | -6.21 | 1.89 | -6.93 | 2.07 |
EBIT Margin | -0.10% | -56.13% | -6.60% | 1.69% | -6.12% | 1.74% |
Effective Tax Rate | 0.69% | 1.04% | -4.32% | -12.26% | -2.95% | -6.31% |